<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02142062</url>
  </required_header>
  <id_info>
    <org_study_id>007-13</org_study_id>
    <nct_id>NCT02142062</nct_id>
  </id_info>
  <brief_title>Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction</brief_title>
  <acronym>VIDIO</acronym>
  <official_title>Prospective, Single-arm, Multi-center, Pilot Study of IVUS Imaging Used as an Adjunct to Multiplanar Venography During Iliac-common Femoral Vein Assessment for Possible Endovascular Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Volcano Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Volcano Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that IVUS identifies more instances of
      significant iliac and common femoral vein outflow obstruction than multiplanar venography.No
      hypothesis testing is planned.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>100 patients with Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP) classification C4-6 undergoing iliac and common femoral and venography with intention to treat venous outflow obstruction.</measure>
    <time_frame>6 month</time_frame>
    <description>Primary Endpoints: Both venous IVUS and traditional venography will provide measurements of minimum and maximum diameter reduction due to iliofemoral venous obstruction/compression; cross-sectional area reduction will also be measured by IVUS, and calculated for venography (from min. and max. diameters, assuming elliptical cross-section6). The diameters and cross-sectional area are compared to adjacent reference vessel in order to calculate the degree of stenosis. The percentage of significant stenosis detected at various thresholds [e.g., 50%, 60%, 70%, 80%, for diameter reduction, and (separately) for area reduction] with each method will be compared in a pair-wise fashion. This will be done with descriptive statistics of the detection rates for each method, and the rate of discordance between the two. In addition to the binary outcome of significant stenosis, the numeric values for diameters and cross-sectional areas will be compared.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Iliac Venous Compression</condition>
  <arm_group>
    <arm_group_label>Venography and IVUS imaging guiding treatment</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with iliac compression disease CEAP classification 4-6. Hospitals, venous clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be &gt; 18 and &lt; 85 years of age

          -  Willing to participate in and able to understand, read and sign the informed consent
             document before the planned procedure

          -  CEAP clinical classification: C4, C5, or C6 (enrollment of C4 and C5 subjects will be
             capped at 50, such that at least 50 C6 subjects can be enrolled)

          -  On duplex ultrasound: patent common femoral vein, and patent deep femoral vein, and/or
             femoral vein of the study leg

          -  Undergoing iliofemoral and inferior vena caval venography with the intent to treat
             obstructive lesions

        Exclusion Criteria:

          -  Subject cannot or will not provide written informed consent

          -  Previous venous stent implantation involving the study leg or inferior vena cava

          -  Previous venovenous bypass surgery involving the study leg

          -  Known metal allergy precluding endovascular stent implantation

          -  Known reaction or sensitivity to iodinated contrast that cannot be managed with
             premedication

          -  Subjects who are pregnant (women of childbearing potential must have a negative
             pregnancy test within 7 days prior to enrollment

          -  Severe, untreated (and readily treatable) superficial venous reflux (great saphenous
             vein &gt;7 mm in diameter, and/or small saphenous vein &gt;4 mm in diameter)

          -  Acute deep venous thrombosis involving either leg

          -  Known history of chronic total occlusion of the common femoral vein of the study leg.

          -  Known history of thrombophilia (e.g., protein C or S deficiency, anti-thrombin III
             deficiency, presence of lupus anticoagulant, etc.)

          -  Venous compression caused by tumor encasement

          -  Venous outflow obstruction caused by tumor thrombus

          -  Life expectancy of less than 6 months

          -  Elevated baseline blood creatinine (value greater than the upper limit of the normal
             range)

          -  Any concurrent disease or condition that, in the opinion of the Investigator, would
             make the subject unsuitable for participation in the study; examples include but are
             not limited to the inability to lie supine for the index procedure (e.g., severe
             congestive heart failure), thrombocytopenia or other hematological disorders
             associated with an unacceptable risk of bleeding, implanted orthopedic hardware that
             precludes proper imaging, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Gagne, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Connecticut Vascular Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35924</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Heart</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern CT Vascular Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norwalk Hospital</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06856</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vein Center of Southwest Louisiana/Imperial Health</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Stony Brook University Medical Center</name>
      <address>
        <city>Stonybrook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospital</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny Vein and Vascular Clinic</name>
      <address>
        <city>Bradford</city>
        <state>Pennsylvania</state>
        <zip>16701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hesperia Hospital</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Przemienienia Pańskiego</name>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, Elamin MB, Duggirala MK, Erwin PJ, Montori VM, Gloviczki P. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011 May;53(5 Suppl):49S-65S. doi: 10.1016/j.jvs.2011.02.031. Review.</citation>
    <PMID>21536173</PMID>
  </reference>
  <reference>
    <citation>Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. Minerva Cardioangiol. 2007 Aug;55(4):459-76. Review. English, Italian.</citation>
    <PMID>17653022</PMID>
  </reference>
  <reference>
    <citation>Raju S, Neglén P. Clinical practice. Chronic venous insufficiency and varicose veins. N Engl J Med. 2009 May 28;360(22):2319-27. doi: 10.1056/NEJMcp0802444. Review.</citation>
    <PMID>19474429</PMID>
  </reference>
  <reference>
    <citation>Neglén P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg. 2002 Apr;35(4):694-700.</citation>
    <PMID>11932665</PMID>
  </reference>
  <reference>
    <citation>Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg. 2006 Jul;44(1):136-43; discussion 144.</citation>
    <PMID>16828437</PMID>
  </reference>
  <reference>
    <citation>Murphy EH, Broker HS, Johnson EJ, Modrall JG, Valentine RJ, Arko FR 3rd. Device and imaging-specific volumetric analysis of clot lysis after percutaneous mechanical thrombectomy for iliofemoral DVT. J Endovasc Ther. 2010 Jun;17(3):423-33. doi: 10.1583/10-3088.1.</citation>
    <PMID>20557187</PMID>
  </reference>
  <reference>
    <citation>Raju S. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013 Apr;57(4):1163-9. doi: 10.1016/j.jvs.2012.11.084. Epub 2013 Feb 20. Review.</citation>
    <PMID>23433816</PMID>
  </reference>
  <reference>
    <citation>Alhalbouni S, Hingorani A, Shiferson A, Gopal K, Jung D, Novak D, Marks N, Ascher E. Iliac-femoral venous stenting for lower extremity venous stasis symptoms. Ann Vasc Surg. 2012 Feb;26(2):185-9. doi: 10.1016/j.avsg.2011.05.033. Epub 2011 Oct 22.</citation>
    <PMID>22018502</PMID>
  </reference>
  <reference>
    <citation>Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, Meissner MH, Rutherford RB; American Venous Forum Ad Hoc Outcomes Working Group. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010 Nov;52(5):1387-96. doi: 10.1016/j.jvs.2010.06.161. Epub 2010 Sep 27.</citation>
    <PMID>20875713</PMID>
  </reference>
  <reference>
    <citation>Stacey MC, Burnand KG, Layer GT, Pattison M, Browse NL. Measurement of the healing of venous ulcers. Aust N Z J Surg. 1991 Nov;61(11):844-8.</citation>
    <PMID>1750819</PMID>
  </reference>
  <reference>
    <citation>Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004 Dec;40(6):1248-52. Review.</citation>
    <PMID>15622385</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2014</study_first_submitted>
  <study_first_submitted_qc>May 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2014</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous outflow obstruction</keyword>
  <keyword>Iliac Vein</keyword>
  <keyword>Common Femoral Vein</keyword>
  <keyword>Iliac Compression</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

